Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Cognitive
Neurogenic, anti-tau peptide derived from ciliary neurotrophic factor — Alzheimer's research.
Peptide B
Cognitive
Neuroprotective ACTH analog with nootropic and neurotrophic properties.
Typical vial
5 mg
Typical dose
Per kg dosing mcg
Half-life
Variable; designed for sustained activity
FDA status
Not FDA approved.
Typical vial
5 mg
Typical dose
200-600 mcg
Half-life
~2-3 minutes (very rapid degradation; biological effects last hours due to downstream gene expression changes)
FDA status
Not FDA approved for human use. Approved in Russia for strok…
P21 (P021) effects
Semax effects
P21 (P021) side effects
Semax side effects
P21 (P021) dosing ranges
Neurogenesis research (preclinical)
40-200 mcg/kg · Daily or alternate-day SubQ · Per research protocol
Semax dosing ranges
Cognitive enhancement
200-600 mcg · Once or twice daily (intranasal) · 10-20 days per course
Neuroprotection / stroke recovery
600-1200 mcg · Two to three times daily (intranasal) · 10-14 days
P21 (P021): Neurogenic, anti-tau peptide derived from ciliary neurotrophic factor — Alzheimer's research. Typical dose Per kg dosing mcg. Semax: Neuroprotective ACTH analog with nootropic and neurotrophic properties. Typical dose 200-600 mcg. Both fall under the Cognitive category.
Stacking P21 (P021) with Semax is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
P21 (P021) is typically dosed: Daily or alternate-day SubQ for Neurogenesis research (preclinical). Semax is typically dosed: Once or twice daily (intranasal) for Cognitive enhancement; Two to three times daily (intranasal) for Neuroprotection / stroke recovery.
P21 (P021): Not FDA approved. Semax: Not FDA approved for human use. Approved in Russia for stroke recovery, cognitive impairment, and optic nerve disease.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free